| Literature DB >> 26177082 |
Tomoyuki Kurose1, Masakazu Hashimoto1, Junya Ozawa2, Seiichi Kawamata1.
Abstract
Pressure ulcers have been investigated in a few animal models, but the molecular mechanisms of pressure ulcers are not well understood. We hypothesized that pressure results in up-regulation of inflammatory cytokines and those cytokines contribute to the formation of pressure ulcers. We measured genome-wide changes in transcript levels after compression, and focused especially on inflammatory cytokines. The abdominal wall of rats was compressed at 100 mmHg for 4 hours by two magnets. Specimens were obtained 12 hours, 1, or 3 days after compression, and analyzed by light microscopy, microarray, Real-Time PCR, and ELISA. The skin and subcutaneous tissue in the compressed area were markedly thickened. The microarray showed that numerous genes were up-regulated after the compression. Up-regulated genes were involved in apoptosis, inflammation, oxidative stress, proteolysis, hypoxia, and so on. Real-Time PCR showed the up-regulation of granulocyte-macrophage colony stimulating factor (GM-CSF), interferon γ (IFN-γ), interleukin 1β (IL-1β), interleukin 1 receptor antagonist gene (IL1Ra), interleukin 6 (IL-6), interleukin 10 (IL-10), matrix metalloproteinase 3 (MMP-3), tissue inhibitor of metalloproteinase 1 (TIMP-1), and tumor necrosis factor α (TNF-α) at 12 hours, IFN-γ, IL-6, IL-10, MMP-3, and TIMP-1 at 1 day, and IFN-γ, IL-6, and MMP-3 at 3 days. Some genes from subcutaneous tissue were up-regulated temporarily, and others were kept at high levels of expression. ELISA data showed that the concentrations of IL-1β and IL-6 proteins were most notably increased following compression. Prolonged up-regulation of IL-1β, and IL-6 might enhance local inflammation, and continuous local inflammation may contribute to the pressure ulcer formation. In addition, GM-CSF, IFN-γ, MMP-3, and TIMP-1 were not reported previously in the wound healing process, and those genes may have a role in development of the pressure ulcers. Expression data from Real-Time PCR were generally in good agreement with those of the microarray. Our microarray data were useful for identifying genes involved in pressure ulcer formation. However, the expression levels of the genes didn't necessarily correspond with protein production. As such, the functions of these cytokines need to be further investigated.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26177082 PMCID: PMC4503587 DOI: 10.1371/journal.pone.0132622
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
A list of Taqman Assay kits used for Real-time PCR.
| Gene Symbol | Gene Name | Assay ID |
|---|---|---|
| β-actin | beta-actin | Rn00667869_m1 |
| GM-CSF | granulocyte-macrophage colony stimulating factor | Rn01456851_m1 |
| INF-γ | interferon gamma | Rn00594078_m1 |
| IL-1α | interleukin 1 alpha | Rn00566700_m1 |
| IL-1β | interleukin 1 beta | Rn00580432_m1 |
| IL-1Ra | interleukin 1 receptor antagonist gene | Rn00573488_m1 |
| IL-2 | interleukin 2 | Rn00587673_m1 |
| IL-6 | interleukin 6 | Rn00561420_m1 |
| IL-10 | interleukin 10 | Rn00563409_m1 |
| MMP-3 | matrix metalloproteinase 3 | Rn00591740_m1 |
| TGF-β1 | transforming growth factor, beta-1 | Rn00572010_m1 |
| TIMP-1 | tissue inhibitor of metalloproteinase 1 | Rn00587558_m1 |
| TNF-α | tumor necrosis factor, alpha | Rn99999017_m1 |
Fig 1Hematoxylin and eosin stained sections of the abdominal wall.
A typical example of each group is shown. a: sham group. The epidermis (E) is very thin. The skin and subcutaneous connective tissue are bordered by cutaneous muscle (CM). D; dermis, SC; subcutaneous connective tissue, M; muscle layer. b: At 12 hours after compression, the skin and subcutaneous connective tissue are markedly thickened. c: At 1 day after compression, the skin and subcutaneous connective tissue are still thickened. d: At 3 days after compression, thickness of skin and subcutaneous connective tissue are decreased. The arrow shows a necrotic area observed at the muscle layer, and many infiltrating cells are existing in this area. Scale bar = 1 mm.
A list of Taqman Assay kits used for Real-time PCR.
| Abbreviation | Gene Name | Probe ID | 12h | 1d | 3d | |||
|---|---|---|---|---|---|---|---|---|
| n = 1 | n = 1 | n = 1 | ||||||
| GM-CSF | granulocyte-macrophage colony stimulating factor | 1371227_at | 8.25 | ↑ | 1.91 | 0.61 | ||
| IFN-γ | interferon gamma | 1370790_at | 0.60 | 25.00 | ↑ | 3.71 | ↑ | |
| IL-1α | interleukin 1 alpha | 1368592_at | 1.96 | 0.72 | 1.42 | |||
| IL-1β | interleukin 1 beta | 1398256_at | 16.95 | ↑ | 0.24 | ↓ | 1.23 | |
| IL1Ra | interleukin 1 receptor antagonist gene | 1387835_at | 8.31 | ↑ | 0.13 | ↓ | 0.98 | |
| IL-2 | interleukin 2 | 1369596_at | 1.08 | 1.22 | 0.60 | |||
| IL-4 | interleukin 4 | 1371128_at | 1.27 | 0.78 | 0.49 | ↓ | ||
| IL-6 | interleukin 6 (interferon, beta 2) | 1369191_at | 82.42 | ↑ | 0.01 | ↓ | 0.74 | |
| IL-10 | interleukin 10 | 1387711_at | 38.32 | ↑ | 0.25 | ↓ | 0.16 | ↓ |
| IL-11 | interleukin 11 | 1369534_at | 6.08 | ↑ | 4.50 | ↑ | 1.07 | |
| IL-12 | interleukin 12 | 1369315_at | 1.11 | 0.59 | 2.85 | ↑ | ||
| LT-α | lymphotoxin alpha (TNF superfamily, member 1) | 1368722_at | 0.74 | 0.53 | 0.78 | |||
| LT-β | lymphotoxin beta (TNF superfamily, member 3) | 1379499_at | 15.21 | ↑ | 0.32 | ↓ | 1.24 | |
| MMP-3 | matrix metalloproteinase 3 | 1368657_at | 22.18 | ↑ | 0.06 | ↓ | 0.61 | |
| TGF-β1 | transforming growth factor, beta 1 | 1370082_at | 1.10 | 0.71 | 0.49 | ↓ | ||
| TGF-β2 | transforming growth factor, beta 2 | 1387172_a_at | 0.69 | 2.72 | ↑ | 1.37 | ||
| TGF-β3 | transforming growth factor, beta 3 | 1367859_at | 1.11 | 2.13 | ↑ | 1.69 | ||
| TIMP-1 | tissue inhibitor of metalloproteinase 1 | 1367712_at | 4.83 | ↑ | 0.36 | ↓ | 0.40 | ↓ |
| TIMP-2 | TIMP metallopeptidase inhibitor 2 | 1386940_at | 0.79 | 1.71 | 0.97 | |||
| TNF-α | tumor necrosis factor, alpha (cachetin) | 1387691_at | 6.05 | ↑ | 0.99 | 1.18 | ||
Relative expression is calculated as the ratio of expression levels in compression group/sham group. Up-pointing arrows: up-regulated over twice, down-pointing arrows: down-regulated less than half.
Fig 2Relative mRNA expression level by Real-Time PCR.
Part of the data of Table 2 were represented by a bar graph. IL-1β in the skin and the subcutaneous tissue (a), IL-1β in the subcutaneous tissue (b). TGF-β1 in the skin and the subcutaneous tissue (c), TGF-β1 in the subcutaneous tissue (d). The dotted line indicates the expression level in the sham group.
Results of Real-Time PCR analysis for inflammatory gene.
| Abbreviation | the skin and the subcutaneous tissue | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12h | 1d | 3d | |||||||
| n = 4 | n = 4 | n = 4 | |||||||
| GM-CSF | 7.85 | (2.93~17.41) | ↑ | 1.71 | (1.00~3.49) | 0.60 | (0.34~1.02) | ||
| IFN-γ | 2.06 | (0.76~3.84) | ↑ | 2.26 | (0.79~5.70) | ↑ | 4.93 | (1.96~8.01) | ↑ |
| IL-1α | 1.97 | (0.86~3.75) | 0.34 | (0.17~0.44) | ↓ | 0.33 | (0.25~0.47) | ↓ | |
| IL-1β | 22.24 | (4.88~41.34) | ↑ | 1.28 | (0.65~1.80) | 1.45 | (0.88~2.16) | ||
| IL-1Ra | 3.98 | (2.04~6.88) | ↑ | 0.73 | (0.59~1.03) | 0.54 | (0.44~0.59) | ||
| IL-2 | 0.64 | (0.16~1.34) | 0.40 | (0.11~0.69) | ↓ | 0.17 | (0.08~0.28) | ↓ | |
| IL-6 | 38.78 | (26.26~66.03) | ↑ | 10.06 | (6.85~12.76) | ↑ | 2.52 | (1.12~4.53) | ↑ |
| IL-10 | 4.36 | (2.23~5.59) | ↑ | 3.95 | (2.46~6.29) | ↑ | 1.07 | (0.71~1.63) | |
| MMP-3 | 9.01 | (3.36~16.10) | ↑ | 12.54 | (5.70~19.05) | ↑ | 2.61 | (1.82~3.42) | ↑ |
| TGF-β1 | 1.13 | (0.56~1.86) | 0.59 | (0.59~1.19) | 1.26 | (1.03~1.74) | |||
| TIMP-1 | 2.93 | (2.00~4.02) | ↑ | 3.35 | (2.07~4.14) | ↑ | 1.54 | (1.27~1.68) |
|
| TNF-α | 17.96 | (3.07~39.39) | ↑ | 1.36 | (0.90~1.64) | 0.77 | (0.59~1.16) | ||
RNAs from the skin and the subcutaneous tissue were analyzed. Values were described as fold changes (minimum value ~ maximum value). Up-pointing arrows: up-regulated over twice, down-pointing arrows: down-regulated less than half.
* p<0.05.
Results of Real-Time PCR analysis for inflammatory gene.
| Abbreviation | the subcutaneous tissue | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12h | 1d | 3d | |||||||
| n = 3 | n = 3 | n = 3 | |||||||
| GM-CSF | 53.76 | (13.32~119.96) | ↑ | 7.52 | (3.25~12.46) | ↑ | 0.16 | (0.04~0.40) | ↓ |
| IFN-γ | 5.33 | (1.43~12.60) | ↑ | 7.87 | (4.02~12.68) | ↑ | 0.64 | (0.09~1.81) | |
| IL-1α | 5.72 | (0.75~12.22) | ↑ | 11.11 | (2.90~25.89) | ↑ | 6.33 | (0.25~18.16) | ↑ |
| IL-1β | 11.27 | (3.31~25.04) | ↑ | 40.87 | (17.29~87.90) | ↑ | 27.47 | (0.92~80.32) | ↑ |
| IL-1Ra | 3.67 | (1.95~6.17) | ↑ | 6.59 | (3.62~12.24) | ↑ | 1.19 | (0.96~1.53) | |
| IL-2 | 1.31 | (0.34~1.95) | 0.61 | (0.53~1.10) | 0.49 | (0.39~0.60) | ↓ | ||
| IL-6 | 2.66 | (1.91~3.07) | ↑ | 9.82 | (2.96~16.46) | ↑ | 6.31 | (3.12~11.94) | ↑ |
| IL-10 | 0.64 | (0.11~1.07) | 0.42 | (0.17~0.66) | ↓ | 2.04 | (1.13~2.58) | ↑ | |
| MMP-3 | 4.38 | (1.30~8.96) | ↑ | 34 | (30.34~36.25) | ↑ | 1.58 | (1.00~1.91) | |
| TGF-β1 | 5.9 | (0.63~8.60) | ↑ | 7.01 | (0.85~11.80) | ↑ | 1.27 | (0.37~3.02) | |
| TIMP-1 | 3.28 | (3.11~3.57) | ↑ | 3.27 | (2.57~4.38) | ↑ | 3.13 | (2.01~4.24) | ↑ |
| TNF-α | 0.68 | (0.48~0.99) | 2.13 | (1.04~4.10) | ↑ | 3.31 | (2.05~3.95) | ↑ | |
RNAs from the subcutaneous tissue were analyzed. Values were described as fold changes (minimum value ~ maximum value). Up-pointing arrows: up-regulated over twice, down-pointing arrows: down-regulated less than half.
Results of the ELISAs for detection of inflammatory cytokines.
| Abbreviation | the skin and the subcutaneous tissue | |||||
|---|---|---|---|---|---|---|
| 12h | 1d | 3d | ||||
| IFN-γ | 0.84 | (0.57~1.14) | 1.44 | (0.76~2.02) | 0.3 | (0.13~0.51) |
| IL-1α | 0.63 | (0.56~0.75) | 0.37 | (0.17~0.62) | 0.52 | (0.37~0.75) |
| IL-1β | 1.61 | (1.02~2.13) | 0.75 | (0.34~1.64) | 0.52 | (0.35~0.63) |
| IL-6 | 1.99 | (0.66~4.02) | 2.49 | (1.42~4.03) | 0.43 | (0.14~0.80) |
| IL-10 | 0.37 | (0.09~0.55) | 1.32 | (0.91~1.71) | 0.52 | (0.34~0.76) |
| TNF-α | 0.28 | (0.20~0.41) | 1.12 | (0.72~1.48) | 0.67 | (0.61~0.79) |
Proteins extracted from the skin and subcutaneous tissues were analyzed. Values were described as fold changes (minimum value ~ maximum value).